Hazard
410 recalls in our database tag this hazard, drawn from FDA, USDA FSIS, CPSC, and NHTSA source notices.
Of the 410 particulate matter recalls we have scored against our rubric, 57 (14%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 186 (45%) are Severe.
Which agencies issued them
Hazard tags are short, machine-readable labels we attach to every recall to make cross-cutting queries possible — “all particulate matter recalls regardless of agency”, “all listeria recalls in California”, “all airbag recalls in 2025”. The tags are extracted from each recall’s source text during the LLM rewrite step and validated against a fixed schema.
A recall can carry multiple tags — a Listeria recall might also be tagged ready-to-eat and undeclared-allergen. Use the full-text search if you want to combine hazard tags with brand or category filters.
Apollo Care, LLC is recalling specific lots of Semaglutide 6.75mg vials because they contain nylon and silk-type particulate matter.
Apollo Care, LLC is recalling specific lots of Semaglutide 9mg vials because they contain nylon and silk-type particulate matter.
Sunny Pharmtech Inc. is recalling 4,077 vials of Cyclophosphamide for Injection due to stainless steel particulate matter found in the product. The recall affects vials distributed nationwide in the USA.
Cyclophosphamide for Injection, USP, 2 gram/vial, is being recalled due to the presence of particulate matter identified as stainless steel. The recall affects 1,464 vials distributed nationwide.
Mylan Pharmaceuticals is recalling one lot of Mycophenolate Mofetil for Injection, 500 mg/vial, because precipitate was found in the vials. The recall covers 5,688 vials distributed nationwide.
Fresenius Kabi is recalling 93,250 vials of Xylocaine (lidocaine HCl) injection due to the presence of particulate matter, specifically hair found in the product.
Fresenius Kabi is recalling 92,600 vials of NAROPIN (ropivacaine hydrochloride) injection, 0.5%, 10/2028, due to the presence of particulate matter, including hair, found in the product.
Fresenius Kabi is recalling Glycopyrrolate Injection due to the presence of particulate matter, specifically hair found in the product.
Buprenorphine HCl Injection, 0.3 mg/mL single dose vials, is being recalled because of crystallization identified as buprenorphine free base. 46,334 units are affected.
Doxorubicin Hydrochloride Liposome Injection, 50 mg/25 mL single-dose vials, is being recalled because of particulate matter identified as glass. 675 vials are affected.
Lupin Pharmaceuticals is recalling Liraglutide Injection due to the presence of white thread-like structures (particulate matter) found in cartridges. The recall affects 217,621 pen injectors distributed nationwide.
Endo USA, Inc. is recalling Buprenorphine Hydrochloride injection vials distributed nationwide due to the presence of particulate matter identified as Buprenorphine free base. The FDA classified this as a Class II recall.
B. Braun Medical Inc. is recalling Lactated Ringer's Injection USP (1000 mL containers) due to the presence of particulate matter. The recall affects 95,412 containers distributed nationwide.
GE Healthcare is recalling Omnipaque (iohexol) Injection, 300 mg/mL, over the presence of particulate matter. The action covers 866,570 vials distributed nationwide.
GE Healthcare is recalling Omnipaque (iohexol) Injection, 350 mg/mL, over the presence of particulate matter. The action covers 306,810 vials distributed nationwide.
Strides Pharma is recalling two lots of Children's Ibuprofen Oral Suspension after complaints of a gel-like mass and black particles in the product.
Radnostix is recalling one batch of Sodium Iodide I-131 Therapeutic Oral Solution because of the presence of particulate matter caused by production issues.
Baxter Healthcare is recalling 125,496 bottles of Sterile Water for Irrigation, 250 mL, after plastic particles from the bottle rim were observed floating in the solution.
Cipla USA is recalling 15,221 prefilled syringes of Lanreotide Injection, 120 mg/0.5 mL, over the presence of particulate matter.
Imprimis NJOF is recalling 314 boxes containing 6,280 pre-filled syringes of Tri-Moxi triamcinolone and moxifloxacin intraocular injection over glass-like particles.
Imprimis NJOF is recalling 596 boxes containing 11,920 pre-filled syringes of Dexamethasone, Moxifloxacin and Ketorolac intraocular injection over glass-like particles.
Imprimis NJOF is recalling 778 boxes containing 15,540 pre-filled syringes of Dexamethasone and Moxifloxacin intraocular injection over glass-like particles.
Novo Nordisk is recalling Wegovy (semaglutide) Injection, 1 mg/0.5 mL prefilled pens, over the presence of particulate matter after hair was found in a prefilled syringe.
Novo Nordisk is recalling Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL prefilled pens, over the presence of particulate matter after hair was found in a prefilled syringe.
Merck Sharp & Dohme is recalling 3 single-dose kits of Emend (aprepitant) for oral suspension over the potential presence of metal particulates in the product.